With 23.55 million shares changed hands, the volume of the stock remained heavier than its average volume of 17820.0 shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.0 whereas the lowest price it dropped to was $1.17. The 52-week range on ANL shows that it touched its highest point at $2.99 and its lowest point at $0.88 during that stretch. It currently has a 1-year price target of $9.00. Beta for the stock currently stands at -1.00.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ANL was up-trending over the past week, with a rise of 18.42%, but this was up by 30.43% over a month. Three-month performance surged to 1.69% while six-month performance rose 22.45%. The stock lost -32.97% in the past year, while it has lost -15.89% so far this year.
Float and Shares Shorts:
On 2025-12-15, short shares totaled 4639.0, which was 1.0 higher than short shares on 1763078400. In addition to Mr. Yang Lu as the firm’s Co- Founder, CEO & Chairman, Dr. Kaiyang Tang serves as its President.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.88 being high and -$0.88 being low. For ANL, this leads to a yearly average estimate of -$0.88.
